J Korean Assoc Oral Maxillofac Surg.
2021 Dec;47(6):480-483. 10.5125/jkaoms.2021.47.6.480.
Autologous blood derived cell therapy in maxillofacial bone graft surgery
- Affiliations
-
- 1Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, School of Dentistry, Seoul National University, Seoul, Korea
- KMID: 2524709
- DOI: http://doi.org/10.5125/jkaoms.2021.47.6.480
Abstract
- Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clinics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was introduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Use of Platelet-rich Plasma
- The reconstruction of posttraumatic craniofacial deformity using modified lefort II and III osteotomy and autogenous iliac bone graft
- Comparison of vertical bone resorption following various types of autologous block bone grafts
- Tissue Engineering of Vascular Graft Using Autogenous Bone Marrow Cell and Allogenous Acellular Vessel
- Temporomandibular joint re-ankylosis: a case report and literature review
